Feliciana Real-Fernández

Dr. Feliciana Real-Fernández

Consiglio Nazionale delle Ricerche, Istituto di Chimica dei Composti Organometallici, Sesto Fiorentino, Italy
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2012 in Sensors
Verified
Journal Article
Open access
PDF file
FFFeliciana Real Fernández
Feliciana Real Fernández
IPIrene Passalacqua
Irene Passalacqua
EPElisa Peroni
Elisa Peroni
MCMario Chelli
Mario Chelli
FLFrancesco Lolli
Francesco Lolli
PRPaolo Rovero
Paolo Rovero
In multiple sclerosis (MS) the gold standard for the diagnosis and prognosis is, up to now, the use of magnetic resonance imaging markers. No alternative simpler assays proven of use, except for cerebrospinal fluid analysis, have been provided in MS diagnosis. Therefore, there is a need to develop non-invasive, sensitive, simple new techniques for the clinical routine. Herein we present the evaluation of the feasibility of a glycopeptide-based biosensor to detect MS specific antibodies in sera using the surface plasmon resonance technology. The previously described glycopeptide antigen CSF114(Glc) has been immobilized on a gold sensor chip and the method has been optimized for real-time specific autoantibody detection directly in sera. A population of 60 healthy blood donors and 61 multiple sclerosis patients has been screened. The receiver operating characteristic (ROC)-based analysis has established the optimal diagnostic cut-off value for the method obtaining a sensitivity of 36% and a specificity of 95%. Sample sera have been also screened with a previously validated ELISA.

1 January 2008 in Peptide Science
Verified
Journal Article
Closed access
PDF file
FFFeliciana Real Fernández
Feliciana Real Fernández
ACAmélie Colson
Amélie Colson
JBJérome Bayardon
Jérome Bayardon
FNFrancesca Nuti
Francesca Nuti
EPElisa Peroni
Elisa Peroni
Anna Maria PapiniAnna Maria Papini
Anna Maria Papini

26 July 2015 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
FFFeliciana Real Fernández
Feliciana Real Fernández
RCRolando Cimaz
Rolando Cimaz
GRGiada Rossi
Giada Rossi
GSGabriele Simonini
Gabriele Simonini
TGTeresa Giani
Teresa Giani
PRPaolo Rovero
Paolo Rovero

23 December 2016 in Scientific Reports
Verified
Journal Article
Open access
MWMarthe Walvoort
Marthe Walvoort
CTChiara Testa
Chiara Testa
RERaya Eilam
Raya Eilam
RARina Aharoni
Rina Aharoni
FNFrancesca Nuti
Francesca Nuti
Anna Maria PapiniAnna Maria Papini
Anna Maria Papini
In autoimmune diseases, there have been proposals that exogenous “molecular triggers”, i.e., specific this should be ‘non-self antigens’ accompanying infectious agents, might disrupt control of the adaptive immune system resulting in serious pathologies. The etiology of the multiple sclerosis (MS) remains unclear. However, epidemiologic data suggest that exposure to infectious agents may be associated with increased MS risk and progression may be linked to exogenous, bacterially-derived, antigenic molecules, mimicking mammalian cell surface glycoconjugates triggering autoimmune responses. Previously, antibodies specific to a gluco-asparagine (N-Glc) glycopeptide, CSF114(N-Glc), were identified in sera of an MS patient subpopulation. Since the human glycoproteome repertoire lacks this uniquely modified amino acid, we turned our attention to bacteria, i.e., Haemophilus influenzae, expressing cell-surface adhesins including N-Glc, to establish a connection between H. influenzae infection and MS. We exploited the biosynthetic machinery from the opportunistic pathogen H. influenzae (and the homologous enzymes from A. pleuropneumoniae) to produce a unique set of defined glucosylated adhesin proteins. Interestingly we revealed that a hyperglucosylated protein domain, based on the cell-surface adhesin HMW1A, is preferentially recognized by antibodies from sera of an MS patient subpopulation. In conclusion the hyperglucosylated adhesin is the first example of an N-glucosylated native antigen that can be considered a relevant candidate for triggering pathogenic antibodies in MS.

1 January 2010 in Peptide Science
Verified
Journal Article
Closed access
PDF file
FNFrancesca Nuti
Francesca Nuti
EPElisa Peroni
Elisa Peroni
FFFeliciana Real Fernández
Feliciana Real Fernández
MBM. Angeles Bonache
M. Angeles Bonache
ACAlexandra Le Chevalier‐Isaad
Alexandra Le Chevalier‐Isaad
Anna Maria PapiniAnna Maria Papini
Anna Maria Papini

1 November 2014 in Analytical Biochemistry
Verified
Journal Article
Closed access
GRGiada Rossi
Giada Rossi
FFFeliciana Real Fernández
Feliciana Real Fernández
FPFilomena Panza
Filomena Panza
FBFrancesca Barbetti
Francesca Barbetti
FPFederico Pratesi
Federico Pratesi
PMPaola Migliorini
Paola Migliorini